Review
doi: 10.1016/S0140-6736(11)61038-6.
Medical therapy for chronic heart failure
Affiliations
- PMID: 21856485
- DOI: 10.1016/S0140-6736(11)61038-6
Item in Clipboard
Review
Medical therapy for chronic heart failure
Lancet.
.
Abstract
Understanding of contemporary pharmacological therapy for chronic heart failure continues to evolve. In this Review, we discuss how findings from clinical trials have caused the roles of old therapies to be expanded and past treatment algorithms to be challenged. Several trials investigating preserved ejection fraction as a measure of heart failure had disappointing results, although important studies are in progress. Many novel therapeutic approaches for heart failure have emerged and are discussed in this review. The pharmacological treatments for heart failure continue to change, with many exciting possibilities for the future.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
The high-risk patient with heart failure with reduced ejection fraction: treatment options and challenges.Clin Pharmacol Ther. 2013 Oct;94(4):509-18. doi: 10.1038/clpt.2013.137. Epub 2013 Jul 12. Clin Pharmacol Ther. 2013. PMID: 23852394 Review.
-
A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.N Engl J Med. 1989 Mar 16;320(11):677-83. doi: 10.1056/NEJM198903163201101. N Engl J Med. 1989. PMID: 2646536 Clinical Trial.
-
Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.Cardiol Clin. 1995 Feb;13(1):5-26. Cardiol Clin. 1995. PMID: 7796432 Review.
-
Vasodilator therapy for decompensated heart failure.J Am Coll Cardiol. 2008 Jul 15;52(3):208-10. doi: 10.1016/j.jacc.2008.03.046. J Am Coll Cardiol. 2008. PMID: 18617069 No abstract available.
-
A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile.Eur J Heart Fail. 2014 May;16(5):483-93. doi: 10.1002/ejhf.64. Epub 2014 Feb 23. Eur J Heart Fail. 2014. PMID: 24574198 Review.
Cited by
-
Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta-analysis of Randomized Controlled Trials.Clin Cardiol. 2016 Jan;39(1):56-61. doi: 10.1002/clc.22473. Epub 2015 Sep 28. Clin Cardiol. 2016. PMID: 26415519 Free PMC article. Review.
-
A novel small molecule compound VCP979 improves ventricular remodeling in murine models of myocardial ischemia/reperfusion injury.Int J Mol Med. 2020 Feb;45(2):353-364. doi: 10.3892/ijmm.2019.4413. Epub 2019 Nov 27. Int J Mol Med. 2020. PMID: 31789413 Free PMC article.
-
AEOL-induced NRF2 activation and DWORF overexpression mitigate myocardial I/R injury.Mol Med. 2025 May 15;31(1):189. doi: 10.1186/s10020-025-01242-1. Mol Med. 2025. PMID: 40375185 Free PMC article.
-
Does 'super-responder' patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center.J Geriatr Cardiol. 2019 Mar;16(3):251-258. doi: 10.11909/j.issn.1671-5411.2019.03.015. J Geriatr Cardiol. 2019. PMID: 31080467 Free PMC article.
-
Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjects.Int J Clin Pharmacol Ther. 2016 Mar;54(3):217-27. doi: 10.5414/CP202458. Int J Clin Pharmacol Ther. 2016. PMID: 26709596 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
